The therapeutic potential of MYSM1 in the maintenance of genome integrity could be explored by targeting the ubiquitinated form of its substrate histone H2A (H2Aub), as well as other components of the MYSM1 interactome, including DNA repair and replication factors, previously implicated in DNA damage responses and melanoma cell survival [92,93]. The gene discussed is MYSM1; the disease is melanoma.